Test Directory
| Test Code | |||
| APIXA | |||
| Test Name | |||
| Apixaban Level | |||
| CPT Codes | |||
| 80299 | |||
| Expected Turnaround Time | |||
| 1 - 2 day | |||
| Clinical Utility | |||
|
Apixaban is an oral factor Xa inhibitor that is indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. It is also indicated for the treatment, prophylaxis, or the reduction in the risk of recurrence of deep vein thrombosis (DVT) or pulmonary embolism (PE). Apixaban does not need to be monitored routinely, however, exceptions may include determination of failure of therapy vs. poor compliance, or potential dose adjustment required for renal or hepatic dysfunction. |
|||
| Specimen and Container Info | |||
|
Specimen Type: Platelet Poor Plasma Collection Container: Light Blue Top (Sodium Citrate) Desired Specimen Volume: 1 mL |
|||
| Collection Instructions | |||
|
|||
| Processing and Submission Instructions | |||
|
Platelet-Poor Plasma Processing Instructions
|
|||
| Transport Instructions | |||
|
Transport to the laboratory frozen. |
|||
| Stability Requirements | |||
|
|||
| Causes for Rejection | |||
|
|||
| Methodology | |||
| Chromogenic | |||
| Reference Intervals | |||
|
See patient report. |
|||
| Alternate Names | |||
|
|||
| Reference Lab | |||
| Quest Diagnostics Nichols Institute | |||
| Testing Schedule | |||
| Routine, 1 time per week | |||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.